UBS(Lux)E.F.-Biotech(USD)P a.USD
LU0069152568
UBS(Lux)E.F.-Biotech(USD)P a.USD/ LU0069152568 /
| NAV2024-04-17 |
Chg.-4.4200 |
Type of yield |
Investment Focus |
Investment company |
| 638.4100USD |
-0.69% |
reinvestment |
Equity
Worldwide
|
UBS Fund M. (LU) ▶ |
Investment strategy
Der aktiv verwaltete Anlagefonds investiert weltweit hauptsächlich in Aktien von Unternehmen mit Bezug zum Biotechnologiesektor.
Der Fondsmanager kombiniert, gestützt auf fundierte Analysen unserer Anlagespezialisten weltweit, sorgfältig ausgesuchte Aktien verschiedener Unternehmen aus unterschiedlichen Ländern und verschiedenen Segmenten der Branche mit dem Ziel, interessante Ertragschancen zu nutzen und dabei die Risiken unter Kontrolle zu halten.
Investment goal
Der aktiv verwaltete Anlagefonds investiert weltweit hauptsächlich in Aktien von Unternehmen mit Bezug zum Biotechnologiesektor.
Master data
| Type of yield: |
reinvestment |
| Funds Category: |
Equity |
| Region: |
Worldwide |
| Branch: |
Sector Biotechnology |
| Benchmark: |
MSCI US Investable Market Biotechnology 10/40 Index (r) |
| Business year start: |
12-01 |
| Last Distribution: |
- |
| Depository bank: |
UBS Europe SE, Luxembourg Branch |
| Fund domicile: |
Luxembourg |
| Distribution permission: |
Austria, Germany, Switzerland, United Kingdom, Luxembourg |
| Fund manager: |
Sara Cotter,Matthew Konosky,Florian Töpfl |
| Fund volume: |
441.38 mill.
USD
|
| Launch date: |
1996-10-15 |
| Investment focus: |
- |
Conditions
| Issue surcharge: |
5.00% |
| Max. Administration Fee: |
1.63% |
| Minimum investment: |
- USD |
| Deposit fees: |
- |
| Redemption charge: |
0.00% |
| Key Investor Information: |
Download (Print version) |
Investment company
| Funds company: |
UBS Fund M. (LU) |
| Address: |
33A avenue J.F. Kennedy, 1855, Luxembourg |
| Country: |
Luxembourg |
| Internet: |
www.ubs.com
|
Assets
| Stocks |
|
98.48% |
| Cash |
|
1.50% |
| Others |
|
0.02% |
Countries
| United States of America |
|
80.08% |
| Denmark |
|
4.07% |
| Germany |
|
3.19% |
| Virgin Islands (British) |
|
3.06% |
| Switzerland |
|
2.72% |
| Netherlands |
|
2.68% |
| Cash |
|
1.50% |
| Bermuda |
|
1.45% |
| Ireland |
|
1.22% |
| Others |
|
0.03% |
Branches
| Pharma/Biotechnology |
|
91.62% |
| Healthcare services |
|
6.86% |
| Cash |
|
1.50% |
| Others |
|
0.02% |
